BMS-181885, a 5-HT 1B/1D receptor ligand, in experimental models predictive of antimigraine activity and coronary side-effect potential

By Saxena P.R.   De Vries P.   Heiligers J.P.C.   Bax W.A.   MaassenVanDenBrink A.   Yocca F.D.  

European Journal of Pharmacology, Vol. 351, Iss. 3, 1998-06 ,pp. : 329-339

Elsevier

Access to resources Recommend Favorite

Functional profile of almotriptan in animal models predictive of antimigraine activity

By Gras J.   Bou J.   Llenas J.   Fernandez A.G.   Palacios J.M.  

European Journal of Pharmacology, Vol. 410, Iss. 1, 2000-12 ,pp. : 43-51

Elsevier

Access to resources Recommend Favorite

Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy

By De Vries P.   Villalon C.M.   Saxena P.R.  

European Journal of Pharmacology, Vol. 375, Iss. 1, 1999-06 ,pp. : 61-74

Elsevier

Access to resources Recommend Favorite

Erratum to: Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy [Eur. J. Pharmacol. 375 (1999) 61-74] 1

By De Vries P.   Villalon C.M.   Saxena P.R.  

European Journal of Pharmacology, Vol. 384, Iss. 2, 1999-11 ,pp. : 243-244

Elsevier

Access to resources Recommend Favorite

On some aspects of validation of predictive quantitative structure–activity relationship models

By Roy Kunal  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 12, 2007-12 ,pp. : 1567-1577

Informa Healthcare

Access to resources Recommend Favorite